Paul Hawran, Director at Plus Therapeutics, holds 123.55K shares in Plus Therapeutics (Ticker: PSTV), holds 115.89K shares in Sequenom (Ticker: SQNM), holds 360.14K shares in Neurocrine (Ticker: NBIX).

See the Hottest Stocks Based on Insider Trading >

Paul Hawran
Plus Therapeutics (PSTV)
Director

Ranked #33,539 out of 78,624 Corporate Insiders

Profitable Transactions

6 out of 9 Profitable Transactions

Average Return

+0.90%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

99.24%

NBIX

0.76%

PSTV

A breakdown of Paul Hawran's holdings

See the Top Stocks by Insiders

Insider Roles

Neurocrine
(NBIX)

Senior Advisor

Plus Therapeutics
(PSTV)

Director

Roles that Paul Hawran holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Plus Therapeutics
(PSTV)

Rating:Informative Buy

Date:Nov 12, 2009 - Nov 12, 2010

Return:+29.10%

The most profitable trade made by Paul Hawran

See the Latest Stocks Traded by Insiders

Paul Hawran's Trading History

PSTV

Plus Therapeutics

May 18, 2015

Director

Uninformative Buy

―

$264.39K

SQNM

Sequenom

Mar 16, 2009

―

Informative Buy

26.90K

$276.97K

NBIX

Neurocrine

―

Senior Advisor

―

$34.42M

List of latest transactions for each holding click on a transaction to see Paul Hawran's performance on stock

See All Insider Trading from Today

Paul Hawran insider profile FAQ

What is the percentage of profitable transactions made by Paul Hawran?

The percentage of profitable transactions made by Paul Hawran is 67%.

What is the average return per transaction made by Paul Hawran?

The average return per transaction made by Paul Hawran is 0.90%.

What stocks does Paul Hawran hold?

Paul Hawran holds: PSTV, SQNM, NBIX stocks.

What was Paul Hawran’s latest transaction?

Paul Hawran latest transaction was an Uninformative Buy of ―.

What was Paul Hawran's most profitable transaction?

Paul Hawran’s most profitable transaction was an Informative Buy of PSTV stock on November 12, 2009. The return on the trade was 29.10%.

What is Paul Hawran's role in Plus Therapeutics?

Paul Hawran's role in Plus Therapeutics is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Paul Hawran Insider Profile

Paul Hawran Plus Therapeutics (PSTV)Director